← Nootropic Dictionary

Cerebral Vasodilator

Vinpocetine

A compound derived from vincamine used to support cerebral blood flow and cognitive function.

Evidence gradeCross-checked · Moderate-high
B+
WeakModerateStrong
4.0/ 5 rating

KÖGN Health grades Vinpocetine as B+ (Moderate evidence) and rates it 4.0 out of 5.

Last reviewed · June 2026

CategorySynthetic · Cerebral Vasodilator
Typical doseStudied at roughly 15–30 mg/day, usually split and taken with food.
AvailabilityOTC

Primary effects

  • Improved memory
  • Increased focus
  • Cognitive support

How it works

Improves blood flow and oxygen utilisation in the brain.

Overview

Vinpocetine is used to enhance cerebral circulation and support cognitive performance, particularly in ageing populations. It may improve oxygen and glucose utilisation in the brain, contributing to mental clarity. However, regulatory status varies by region, and long-term safety data is still being evaluated.

The evidence

Vinpocetine, derived from the periwinkle alkaloid vincamine, is used in several countries for cerebrovascular disorders. A Cochrane review concluded there is insufficient evidence to support its use for cognitive impairment or dementia, and it failed to help in Alzheimer's trials. The cognitive case in healthy people is weak; its safety record, however, is good.

How to dose it

Studied at roughly 15–30 mg/day, usually split and taken with food.

When to take it

Both — some acute cerebral-blood-flow effects, studied over weeks.

Safety & side effects

Generally well tolerated; occasional GI upset, flushing or sleep disturbance.

Who should avoid it

Regulators have flagged that vinpocetine is not a lawful dietary-supplement ingredient in some regions (including the US), and that it may cause harm in pregnancy (reduced fetal growth) — it should be avoided by anyone pregnant or who may become pregnant. It can also have mild blood-thinning effects; discuss with a clinician if you take anticoagulants.

References

Related ingredients

Graded entries that target the same cognitive goals.

Categories

Synthetic NootropicsBlood Flow & CirculationMemory & LearningNeuroprotection & LongevityLong-Term Cognitive SupportOver-the-Counter (OTC)Moderate-High Evidence

Draft — the dose, safety and evidence notes on this entry were prepared from the published literature and are pending editorial and clinical review.

Educational information, not medical advice. The evidence grade is KÖGN’s editorial assessment of published research, not a health claim. Speak to a qualified clinician before changing what you take.